TSXV: VXL       Vaxil Bio Ltd
Last Price Today's Change   Day's Range   Trading Volume
0.09   0.00 (0.00%)  0.00 - 0.00  0


Avg Volume (4 weeks):295,648
4 Weeks Range:0.075 - 0.12
4 Weeks Price Volatility (%):
52 Weeks Range:0.06 - 0.335
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Vaxil Bio Ltd., formerly Emerge Resources Corp., is an immune-oncology biotechnology company. The Company is engaged in research and development of ImMucin vaccine to treat cancer. The Company develops immunotherapies, including neoantigen peptide products, and antibodies to treat cancer and infectious diseases. The Company offers VaxHit platform, which allows for identification, isolation and production of specific antigen-based immunotherapy products. The Company offers its products from VaxHit technology, which uses the signal peptide (SP) domain in selected targets as core antigens. The Company's product, ImMucin, which has received orphan drug status and designed for the treatment of multiple myeloma (MM) cancer. The Company's ImMucin is in Phase I clinical trial to treat antigen specific immunotherapies; SPmAb2 and SPmAb6 are in pre-clinical stage to treat SP specific antibodies, and MTbuVax is in pre-clinical stage to treat anti-infectives.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor


Top 10 Active Counters
 AAB 0.0550.00 
 AAV 2.060.00 
 TD.PF.A 19.570.00 
 ABX 30.860.00 
 CF.DB.A 106.000.00 
 XHU 23.230.00 
 ACD 6.680.00 
 ACO.X 39.100.00 
 ACQ 29.090.00 
 ROE 0.0750.00